Accentia Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice

Accentia Biopharmaceuticals Inc. reported a net loss of $11.4 million, or 25 cents a share, for its fiscal third quarter ended June 30, compared to a net loss of $25 million, or 71 cents a share, in last year's quarter. (ABPI)

Comments are closed.